📰 Loss Attributable News
Page 20 - Loss Attributable News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Loss Attributable. Real-time updates on events, politics, business and more.
November 3, 2022
– Presented Positive Data from Phase 3 DeFi Trial Evaluating Nirogacestat in Adult Patients with Progressing Desmoid Tumors at the European Society for...
November 3, 2022
Second Quarter Revenue was $875.2 Million; Operating Loss was $1.75 BillionOperating Loss was $53.7 Million Before Impact of Non-Cash Goodwill Wri...
November 2, 2022
Third-Quarter 2022 Financial Results Revenues of $942 Million GAAP Net Loss Attributable to Bausch + Lomb Corporation of $18 Million Adjusted EBITDA...
November 2, 2022
Third-Quarter 2022 Financial Results Revenues of $942 Million GAAP Net Loss Attributable to Bausch + Lomb Corporation of $18 Million Adjusted EBITDA...
November 1, 2022
Highlights: Q3 2022 consolidated revenues of $840.1 million increased 12.3% over Q3 2021 primarily due to increased lift truck prices and parts volumes across...
November 1, 2022
Highlights: Q3 2022 consolidated revenues of $840.1 million increased 12.3% over Q3 2021 primarily due to increased lift truck prices and parts volumes across...
October 28, 2022
Net 117 75 20 ... | October 28, 2022
October 14, 2022
/PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company"), a provider of technology solutions and operation services for intelligent...
October 14, 2022
/PRNewswire/ -- ReTo Eco-Solutions, Inc. (Nasdaq: RETO) ("ReTo" or the "Company"), a provider of technology solutions and operation services for intelligent...
September 28, 2022
/PRNewswire/ -- Ryvu Therapeutics (WSE: RVU), a clinical-stage drug discovery and development company focusing on novel small molecule therapies that address...